A 12-week Post-marketing, Observational Study to Confirm the Safety and Efficacy of Zetia Alone or in Combination With Other Lipid-lowering Drugs in Japanese Subjects With Hypercholesterolemia (Study P05244)

NCT00704444 · clinicaltrials.gov ↗

COMPLETED

Status

11332

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia
Familial Hypercholesterolemia
Homozygous Sitosterolemia

Interventions

DRUG: Ezetimibe
DRUG: Ezetimibe + other lipid-lowering medication(s)

Sponsor

Organon and Co

Collaborators

[object Object]